Adherence to Aromatase Inhibitors: The Role of Partners

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Observational

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: Accepts Healthy Volunteers

• Women and partners of women with stage I-III breast cancer who

• have completed primary cancer treatments (surgery, chemotherapy, radiotherapy)

• have experienced AI side effects

• live with a romantic partner.

United States
Abramson Cancer Center of the University of Pennsylvania
Time Frame
Start Date: July 2014
Completion Date: April 22, 2016
Target number of participants: 40
Related Therapeutic Areas
Leads: Abramson Cancer Center of the University of Pennsylvania

This content was sourced from

Similar Clinical Trials